Patent 11859250 was granted and assigned to CHILDREN'S HOSPITAL MEDICAL CENTER on January, 2024 by the United States Patent and Trademark Office.
The present invention relates to methods for identifying an EoE endotype of a patient and treating the patient with one or more therapies targeted to the patient's disease endotype; and related methods for stratifying patients for clinical trials.